Generic drugs should be cheap, but insurers are charging thousands of dollars for them

Wall Street Journal

11 September 2023 - Health insurers mark up prices of generics for cancer, multiple sclerosis and other complicated diseases.

The cancer drug Gleevec went generic in 2016 and can be bought today for as little as $55 a month. But many patients’ insurance plans are paying more than 100 times that.

Read Wall Street Journal article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Pricing , Generic medicine